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ABSTRAGT 
The effect of computer-reported clinical information on the 
cardiologist's behavior in the interpretation of electrocardiograms 
(EGGs) was studied using 100 inpatient EGGs. Using an automated 
medical record system (HELP), the pertinent demographic and clinical 
information was printed on a clinical label. Two cardiologists inde-
pendently read these 100 EGGs twice, once without the label and once 
with the label provided. A sample of twenty-five EGGs was chosen 
from the 100 EGGs for estimation of intraobserver variability. 
These twenty-five EGGs were independently read again with and without 
the clinical label. An appropriate time delay between the readings 
was allowed to insure independence of the readings. 
The following results were observed: (a) The myocardial 
infarction (MI) and chamber enlargement interpretations, the intra-
observer variability of one cardiologist was reduced from 25 percent 
to 14.7 percent and a corresponding decrease from 22.7 percent to 
6.7 percent for the other cardiologist. Statistically, the decreases 
in both cases were found to be significant. (b) The overall inter-
observer variation showed statistically insignificant reduction 
(16.3 percent to 13 percent). However, for MI interpretation, the 
corresponding reduction from 24 percent to 13 percent might be 
clinically significant. (c) For MI, chamber enlargement and repolar-
ization change interpretations; the frequency of agreement between 
the cardiologists was approximately 2.00 times that of the disagreement 
in the diagnoses. (d) For the interpretation of repolarization changes 
in the twenty-five EGGs, the frequency of changes from nonspecific 
to a specific interpretation increases from 2 percent to 36 percent 
after the introduction of the clinical label. Therefore, it was con-
cluded that the availability of demographic and clinical information 
in a total hospital information system provides useful data to the 
cardiologist for the interpretation of EGGs. 
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CHAPTER I 
BACKGROUND AND OBJECTIVES 
Background 
In spite of recent achievements in the field of medicine, 
cardiac disease remains the leading cause of death in the United 
States. One study showed that the mortality rate from myocardial 
infarction (MI) during hospitalization ranges from 10 to 16 percent 
(Weinblatt, Shapiro, and Frank, 1968; Bigger, Heller, Wenger, and 
Weld, 1978). In another study (Friedman, Klatsky, and Siegelaub, 
1977), it was found that 61.4 percent of the 1,077 sudden deaths 
investigated in the forty to sixty-four age group were due to coronary 
heart disease. In a separate study (Yanushekickus, Bluzhas, and 
Milashauskene, 1977), it was found that the overall proportion of out-
of-hospital sudden deaths due to acute MI and acute coronary insuf-
ficiency was as high as 54.2 percent in 1975. The high percentages 
of out-of-hospital deaths due to cardiac disease in this study indi-
cate that a more meticulous examination of the problem may be 
rewarding. 
One of the many reasons for the high number of cardiac deaths 
outside the hospital is inaccurate diagnosis. In a necropsy study 
(Johnson, Achor, Burchell, and Edwards, 1959), it was found that 
50 percent of the patients with healed infarcts had no record of 
clinical diagnosis of MI during their lifetime; 40 percent of the 
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patients with acute MI, including some with healed infarcts, also 
had no clinical diagnosis of MI during their lifetime. These high 
percentages of inaccurate or incomplete diagnoses of cardiac disease 
indicate that the procedure needs improvement. 
Cardiac disease, if not diagnosed and treated, is very often 
fatal. In order to reduce the number of deaths due to cardiac 
disease, it is essential to minimize the number of patients who have 
an unrecognized cardiac problem. To achieve an accurate diagnosis, a 
good diagnostic method is needed. Ever since the nineteenth century 
a series of invasive and noninvasive diagnostic methods have been 
explored to assess the status of the cardiac function. This thesis 
will concentrate on one such noninvasive diagnostic method--the 
electrocardiogram (ECG). 
An ECG is a graphical recording of electrical potentials 
produced in association with the cardiac cycle. By applying elec-
trodes at various positions on the body and connecting these elec-
trodes in various combinations to an electrical potential recording 
device, the ECG can be recorded. The development of electrocardio-
graphy dates back to the eighteenth century. In 1787, Professor 
Aloysio L. Galvani (1737-1798) at the University of Bologna introduced 
the concept that living tissues have electrical properties. Efforts 
were then made to record the activity of the human heart, but it was 
not until 1887 that Augustus D. Waller, an outstanding physiologist 
in London, first demonstrated at St. Mary's Hospital Medical School 
how to record the electrical activity with a capillary electrometer. 
The recording was then called a cardiogram. 
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Willem Einthoven of Leiden University in Holland developed 
a procedure for recording the electrical activity of the heart. After 
working for a number of years with a capillary electrometer, Einthoven 
became dissatisfied with the records obtained with this instrument. 
This led him to develop the string galvanometer in 1903. The recording 
was then called an elektrokardiogram (EKG). Since then, Einthoven's 
string galvanometer has been refined and modified. It was not until 
1909 that the electrocardiograph was first introduced in the United 
States by Alfred E. Cohn. In 1913, Einthoven and his associates 
introduced "Einthoven's Triangle,1t which formed the foundation of 
clinical electrocardiography. A three-lead system was developed from 
this concept. Later, however, Einthoven's original three leads were 
recognized as inadequate for the study of electrical forces in planes 
other than the frontal plane. In the early 1930s, Frank N. Wilson 
and his group published their first observation concerning a central 
terminal of zero potential. By assuming the concept of Einthoven's 
Triangle, they constructed a lead system which could determine a point 
whose electrical potential could be defined as zero. Potential var-
iations at any point on the body could be measured against this point 
which is called the Wilson terminal. Using this concept, he developed 
a six-lead system to measure the electrical activity of the heart in 
the horizontal plane. This finding later formed the basis for the 
Wilson lead system. 
During the 1930s, the changes in theories and lead configura-
tions were too rapid. Finally in 1938, the American Heart Association 
and the Cardiac Society of Great Britain and Ireland spent a 
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considerable amount of effort to bring order to the field by agreeing 
on six positions for the chest electrode. The positions were defined 
on the basis of the landmarks of the bony thorax. 
By the mid-194Gs, Wilson's "V" leads were widely accepted. 
Later, Dr. Emanuel Goldberger suggested a modification of Wilson's 
"V" lead configuration. He observed that in Wilson's lead system, the 
potential variation at an extremity is fed into both sides of the 
galvanometer at the same time, once through inclusion in the central 
terminal connected to the negative pole and once through the exploring 
electrode connected to the positive one. He reasoned that if the 
connection of an extremity to the central terminal was interrupted, 
there would be an increase in amplitude of the deflection with no 
change in configuration. From this discovery, he developed an addi-
tional three leads. By the end of World War II, Dr. Goldberger's 
three-lead configuration was added to the existing lead system. 
These configurations have evolved into today's twelve-lead system. 
During the period between the two world wars, a better 
clinical understanding of coronary artery disease, especially MI, was 
obtained. Hence, the value of electrocardiography in the diagnosis 
of cardiac disease had increased. Meanwhile, the recording system 
has been refined and modified to a more stable, dependable, and 
sensitive system. Amplifiers were built into the system; direct-
writing and oscilloscope-display electrocardiographs were developed. 
At present, the twelve-lead tracing continues to be the standard for 
recording electrocardiograms. Efforts continue to be made to improve 
instrumentation with a view to better electrocardiographs. 
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Instrumentation in any recording system is important. However, the 
clinical application of the recording is more important. The intel-
ligence that is built into the organization and interpretation of the 
recorded information is the essence of the diagnostic method. There-
fore, the diagnoses that rely on the interpretation of an ECG are the 
prime reasons for the existence of electrocardiography. The ECG 
is especially valuable in clinical conditions, such as atrial or 
ventricular hypertrophy, MI, arrhythmias, pericarditis, systemic 
diseases that affect the heart, the effect of cardiac drugs, and dis-
turbances of the metabolism of electrolytes. The ECG has been shown 
to be both useful and accurate. It was demonstrated (Zinn and Cosby, 
1950) in one study that the twelve-lead ECG used in diagnosing MI was 
correct 80 percent of the time. In another study (Paton, 1957), the 
electrocardiographic diagnosis of confirmed MI was found to be correct 
in ninety-one out of ninety-seven cases (93.81 percent). Nevertheless, 
electrocardiography is an imperfect diagnostic tool for the presence 
of acute or residual cardiac diseases or arrhythmia. One of the 
limitations lies in the interpretation of the recorded information. 
The interpretation of the ECG depends not only on the past experiences 
of the cardiolgoist, but also upon the definition of a "normal" ECG. 
Kossman (1959) said, "One of the most difficult tasks which confronts 
the worker in life sciences is to define a normal. This difficulty 
is compounded when the measurement to be made is affected by many var-
iables which differ in importance from time to time" (p. 920). This 
statement is very appropriate for the discussion of an ECG. 
With the difficulty in defining a "normal,1I there is 
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considerable variation in the interpretation of the same ECG among 
cardiologists. One of the reasons that contributes to this variation 
may be the nonavailability of specific demographic and clinical 
information associated with the patient to the reader of the ECG. In 
most instances, the cardiologist does not have this information when 
the ECG is interpreted. Hence, the cardiologist, using past 
experiences, compares the patient's ECG to a standard "normal" ECG. 
Thus, the interpretation is not patient specific. Nevertheless, all 
cardiologists know that demographic information of the patient, such 
as age, body weight, height, chest configuration, anatomic position 
of the heart, and race, do have an effect on the electrocardiographic 
tracing. That is to say, every patient has his or her own "normal" 
ECG. Clinical information on the patient also helps to define the 
patient's normal ECG. For instance, the laboratory findings, such 
as creatinine phosphokinase, become invaluable to a cardiologist when 
a patient is suspected to have had a heart attack, but the ECG shows 
no abnormalities. Moreover, echocardiography, chest X-ray, and cardiac 
catherization are additional diagnostic tools being employed to 
evaluate the cardiac status. Information which may be unobtainable 
from the patient's electrocardiographic tracing may show up in the 
echocardiogram, the chest X-ray film, or the cardiac catherization 
result. This information may be revealing to a cardiologist when the 
ECG shows a borderline case of cardiac abnormality. Also, the 
medical history of the patient can provide clues which may elicit a 
better comprehension of the patient's health status. For example, a 
history of hypertension is generally suggestive that the patient has 
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some underlying cardiovascular disease. Indeed, most patients who 
develop ventricular fibrillation have a history of hypertension. In 
addition, knowing which cardiac medication the patient is taking 
allows the cardiologist to recognize some of the abnormal electro-
cardiographic findings that may result from the medications and not 
from physiological abnormalities. Thus, it seems that a complete 
clinical picture of the patient is essential for a cardiologist to 
make an accurate interpretation of an ECG. 
Above all, providing the best health care to hospitalized 
patients is the prime interest of the hospital medical team. It is 
unfair to a patient if some pertinent clinical information is absent 
when the ECG is interpreted. On the other hand, it is currently not 
practical for every cardiologist to search the patient's chart to 
retrieve the pertinent clinical information for every ECG read. 
Presently at the LDS Hospital located in Salt Lake City, Utah, the 
patient's clinical information is recorded on his or her chart, but 
is not available to the cardiologist when the interpretation is 
made. In an attempt to solve this problem, the automated medical 
record system (HELP), which was developed by Dr. Homer L. Warner and 
his associates, was employed. The system enables pertinent informa-
tion for interpretation of the ECG to be provided to the cardiologist. 
With the clinical information made available to the cardiologist, 
the change in ECG interpretive behavior may be observed and evaluated. 
Objectives 
The objectives of this study are to observe and to evaluate 
any changes in the cardiologist's interpretation of the ECG after 
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the clinical label, which contained pertinent demographic and clinical 
information, was provided. It is also the purpose of this study to 
evaluate the type of changes that took place. 
CHAPTER II 
DESIGN AND METHODOLOGY 
Introduction 
Currently, there is a tremendous amount of demographic and 
clinical information recorded in the patient's chart. It is imprac-
tical for a cardiologist to retrieve the information from the 
patient's chart for every ECG read. However, the method and the time 
needed for the retrieval of this information can be improved if a 
computerized medical record system is employed. Therefore, the 
automated medical record system (HELP) at the LDS Hospital is ideal 
for this study. 
This chapter describes the overall design of the study, 
describes the type of information to be retrieved and printed on the 
clinical label, justifies the choice of the information, describes 
the protocol used for data collection, and gives the definitions of 
changes of diagnoses. 
Overall Design 
When an ECG was ordered by the attending physician, a copy 
of the order was automatically printed out at the ECG laboratory. 
A technician recorded the patient's tracing at bedside and used a 
questionnaire, which consisted of five questions, to obtain the 
patient's past medical history. The five questions used are shown 
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in Table 1. 
After returning to the ECG laboratory, the recorded information 
was stored in the patient data file through data entry. A computer 
program, which was encoded in the TAL language, was invoked to 
retrieve and print the demographic and clinical information on a 
one and three-fourths inches by ten and one-half inches clinical label 
which was then attached to the ECG of the patient. Thus, the informa-
tion was made available to the cardiologist when the ECG was inter-
preted. Figure 1 summarizes the flow of information and Figure 2 
depicts the overall logic of the computer program. 
Type of Information To 
Be Retrieved 
Speed of retrieval of pertinent information from the patient's 
chart is essential for efficient medical care of the patient, but the 
content of the retrieved information is even more important. If the 
retrieved clinical information is irrelevant to the context of the 
interpretation, it serves no purpose and may confuse the ECG reader. 
Therefore, an experienced and competent cardiologist (Dr. Arthur 
Hagan) was chosen to select a group of demographic and clinical in-
formation from the patient's data file. Table 2 shows a list of the 
demographic and clinical information retrieved. 
The retrieval of the interpreted results of cardiac catheri-
zation required twenty-six HELP sector decisions to provide the data 
of interest in the study. These HELP sector decisions are listed in 
Appendix A. The length of the text in the HELP sector results was 
too long to be printed out on the clinical label, so a list of 
11 
TABLE 1 
QUESTIONNAIRE USED TO OBTAIN PAST MEDICAL 
HISTORY OF THE PATIENT 
Questions 
1. Any previous heart attack? 
2. Any past coronary artery 
bypass graft? 
3. Any history of hypertension? 
4. Any past valvular surgery? 
5. Any history of rheumatic 
valvular disease? 
Responses 
If YES, state the year of 
occurrence. If it happened 
in the current year, state 
the month of occurrence also. 
If YES, give the year of 
occurrence. If it happened 
in the current year, state the 
month of occurrence also. 
YES or NO 
YES or NO 
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LIST OF DEMOGRAPHIC AND CLINICAL INFORMATION TO BE 
RETRIEVED FROM THE PATIENT DATA FILE 
A. Admitting Diagnosis 
B. Demographic Information: 
1. Patient's Name 
2. Patient's Age 
3. Patient's Weight 
4. Patient's Height 
C. Medical History of the Patient: 
1. Previous Heart Attack (Month and Year of Occurrence) 
2. Past Coronary Artery Bypass Graft (Month and Year of 
Occurrence) 
3. Past History of Hypertension 
4. Past Valvular Surgery 
5. Past Rheumatic Valvular Disease 
D. Current Cardiac Medications of the Patient: 
1. Digitalis-Type of Medications 
2. Diuretic-Type of Medications 
3. Quinoidine or Procainamide 
E. Laboratory Findings: 
1. Enzymes: 
a. Creatinine Kinase 
b. Creatinine Kinase MB Isoenzymes 
2. Electrolytes: 
a. Potassium Level 
b. Calcium Level 
F. HELP Decisions! 
1. Chest X-ray Diagnoses in Four Areas: 
a. Cardial or Pericardial Enlargement 
b. Obstructive Pulmonary Disease or Emphysema 
c. Pulmonary Artery Hypertension 
d. Congestive Heart Failure 
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2. Cardiac Catherization Diagnosis from Twenty-two HELP Sectors 
3. Echocardiographic Diagnoses in Free Text Form 
abbreviations was compiled. The list is described in Appendix A. 
The peak values of cardiac enzymes were of interest to the 
cardiologist. Hence, the maximal values of creatinine kinase and 
its MB isoenzyme level were printed. In the retrieval of chest 
X-ray diagnoses, there were four HELP sector decisions which were 
relevant to the study. In addition, along with the test results or 
HELP sector decisions, the time at which the information was stored 
was also recorded on the clinical label. 
Justification of the Clinical 
Information 
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Table 3 shows the information that might affect the interpre-
tation of ECGs in three categories of diagnoses. The following is 
a brief justification for the inclusion of each item (a more detailed 
description of the justification is beyond the scope of this review): 
1. Admitting diagnosis: It provides some knowledge of the 
patient's symptoms. 
2. Age: With advancing age, the amplitudes of the P waves, 
QRS complex, and ST-T segment are reduced significantly (Simonson, 
1972); the duration of P wave is increased; the QRS axis shifts 
left. 
3. Weight: There is a reduction of amplitudes in the QRS 
complex and T waves with increasing weight (Simonson, 1952, 1972). 
4. Height: The correlation of electrocardiographic changes 
with height is comparatively less significant than weight. 
5. Medical history: The information of previous infarction 
and coronary artery bypass graft assists the cardiologist to 
TABLE 3 
INFORMATION THAT FACILITATES THE INTERPRETATION OF ECGs 
Hyocardial Chamber Repolarization 
Information Infarction Enlargement Abnormalities 
A. Admitting Diagnosis X X X 
B. Demographic Information: 
1. Patient's Age X X X 
2. Patient's Weight X 
3. Patient's Height X 
C. Medical History of the Patient: 
1. Previous Infarction X X X 
2. Past Rheumatic Valvular Disease X 
3. Past History of Hypertension X X 
4. Past Coronary Artery Bypass Graft X 
5. Past Valvular Surgery X X X 
D. Current Cardiac Medications: 
1. Digitalis X 
2. Diuretics X 
3. Quinoidine or Procainamide X 
E. Laboratory Findings: 
1. Enzymes: 
a. Creatinine Kinase X X 
b. Creatinine Kinase MB X X 
2. Electrolytes: 
a. Potassium X 1--1 
b. Calcium X 0\ 
Information 
F. HELP Diagnoses: 




a. Cardial/Pericardial Enlargement X 
b. Chronic Obstructive Pulmonary 
Disease 
c. Pulmonary Artery Hypertension 
d. Congestive heart failure 
2. Echocardiographic Diagnoses 
















NOTE: X = this information facilitates the ECG interpretation of myocardial infarction, chamber 




recognize electrocardiographic findings of old infarction; the 
information of history of valvular surgery, rheumatic valvular 
surgery, or hypertension may suggest the presence of chamber en-
largements. 
6. Cardiac medications: Digitalis causes a gradual downward 
sloping of ST segment. Diuretic types of medication may cause 
hypokalemia which is manifested as flattening of the T wave and 
the appearance of a U wave. Quinoidine and procainamide may cause 
depression of the ST segment and prolonged QT interval. 
7. Cardiac enzymes: Creatinine kinase and its isoenzyme 
of MB have a higher sensitivity (98 percent and 100 percent, 
respectively) than ECG (66 percent) in the detection of acute 
MI (Wagner, Roe, Limbird, Rosati, and Wallace, 1973). 
8. Electrolyte levels: In hyperkalemia, the P wave is 
flattened, the QRS complex is widened, and the T wave becomes 
peaked; in hypokalemia, the T wave becomes flattened and the U 
wave appears; in hypercalcemia QT interval is shortened; and 
in hypocalcemia, it is prolonged. 
9. Chest X-ray: It provides helpful information in the 
recognition of chamber enlargements. 
10. Echocardiogram and the interpreted results of cardiac 
catherization: These provide information concerning the cardiac 
function. 
Design and Methods for 
Data Collection 
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The 100 patients in the sample were chosen randomly and con-
secutively from the coronary care unit of the hospital by the tech-
nicians of the ECG laboratory. The patients' electrocardiographic 
tracings were recorded and collected. In addition, the corresponding 
clinical labels were printed and gathered. A protocol was followed 
to distribute the ECGs to the cardiologists to read. The study was 
conducted in two parts. The first part compared the ECG interpreta-
tions before and after the clinical label was provided. The changes 
in the interpretations of the 100 ECGs after the introduction of the 
label were evaluated. The second part of the study was an estimation 
of the intraobserver variation. The protocol for distributing ECGs 
to both cardiologists in the two parts of the study is described as 
follows: 
1. Part I: (a) One hundred ECGs were read by the two 
cardiologists independently without the clinical label. (b) A 
month delay was allowed to ensure independence of the readings. 
(c) The 100 ECGs were then read by them again for the second time 
with the clinical label provided. (d) The changes in the inter-
pretations of the 100 ECGs were evaluated for both cardiologists. 
(e) Another month delay was allowed. 
2. Part II: (a) A sample of twenty-five ECGs (already read 
once twice by both cardiologists, once without the label and once 
with the label) was randomly chosen from the 100 ECGs; these 
ECGs were read by the cardiologists again without the clinical 
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label. (b) A time delay of one month was allowed. (c) The 
twenty-five ECGs were read again for the last time with the 
clinical label provided. (d) The changes in the interpretations 
in the four readings of the twenty-five ECGs were evaluated in 
order to estimate the interobserver variation of both cardio-
logists. 
Definition of a Change in Diagnosis 
In an attempt to evaluate the changes in the cardiologists' 
behavior in the interpretations of ECGS, four categories of electro-
cardiographic diagnoses were chosen to be considered. They are listed 
as follows: 
1. Myocardial infarction (MI) 
2. Atrial enlargement 
3. Ventricular enlargement 
4. Repolarization abnormalities. 
During the development of the algorithm for the computerized 
interpretation of ECGS at the LDS Hospital, computer codes were 
developed for the representation of many abnormalities which may 
appear in the electrocardiographic tracings. For the purpose of our 
study, this computerized coding system makes it easier to measure any 
difference(s) between two sets of interpretations. Thus, the study 
employed this computerized coding system to represent the interpreta-
tions and to define the difference between two ECG diagnoses. 
The corresponding computer codes for the four categories of 
diagnoses described above are listed in Appendix B. In addition, 
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modifiers were also used in the study to provide more descriptive 
information of the diagnoses. The list of modifiers is described in 
Appendix B also. 
The same computer codes may be interpreted differently by the 
two cardiologists. On the other hand, two different codes may 
actually have equivalent context. Hence, the groups of equivalent 
codes must be identified. In other words, computer codes which are 
considered equivalent should be classified under a group. Significant 
changes in the diagnosis are defined by a change in diagnostic group. 
The description of the equivalent groups and the definition of a change 
in diagnosis are described in Appendix C. 
CHAPTER III 
RESULTS AND EVALUATION 
Introduction 
In order to have a thorough evaluation of the data, several 
areas are considered. They are listed as follows: 
1. Due to problems in data entry and incomplete database, 
some of the information is not present on the label. The fre-
quency of the presence of the information on the clinical label 
indicates the availability of data in the patient data file. The 
frequency with which the clinical label is informative relative 
to each category is counted. 
2. The intraobserver variation is estimated in order to 
assess the percentages and frequency of changes which might be 
attributable to the clinical label. 
3. The interobserver variation is used to evaluate the extent 
of disagreement between the two cardiologists both before and 
after the clinical label was made available to them. 
4. The directions of the changes in the cardiologists' 
interpretations are tabulated to provide information concerning 
their reading of the ECGs. Convergent behavior means their 
diagnoses do not agree with each other in the first reading of 
the ECGs; but after the second reading, their diagnoses agreed. 
Divergent means the exact opposite. In addition, if the changes 
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are in the opposite directions (disagree both before and after 
the label was provided), it is classified as divergent behavior. 
5. The changes in the specificity of the ECG interpretations 
of the repolarization changes are considered to suggest how the 
clinical label may affect the cardiologists' interpretive behavior. 
6. The type and frequency of some clinical information when 
there are changes in the interpretations are counted to assess 
the relationship between the changes and the presence of the 
specific clinical information. This is especially relevant in 
the cases where both cardiologists changed their diagnoses in the 
same direction. 
It should be noted that the changes in the modifiers in the 
ECG diagnoses would reflect the interpretive behavior of the cardio-
logists. However, because one of the cardiologists misunderstood the 
study design with respect to the use of modifiers, the analysis of 
the changes in modifiers was not done. 
This chapter gives an account of the overall results of the 
study and describes the results and evaluations pertaining to the six 
areas mentioned. 
Overall Changes in the Four Categories 
of ECG Diagnoses after the Clinical 
Label Was Made Available To 
the Cardiologists 
The protocol, which was described in Chapter II, for the first 
two readings of the 100 ECGs was followed. The frequency of MIs, 
atrial enlargements, ventricular enlargements, and repolarizing 
abnormalities was counted both before and after the clinical label 
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was made available to the two cardiologists. The results of the fre-
quency count and the net difference between the frequency counts 
before and after the label are shown in Table 4. The frequency count 
for infarction was based on specific sites; in other words, if there 
were diagnoses of more than one infarction at two different locations 
in one patient, it was counted as two infarctions. The frequency of 
chamber enlargements was counted in a similar manner. Because in most 
instances both cardiologists agreed or disagreed that there was some 
form of repolarization abnormality, the presence of any form of abnor-
mality was counted regardless of the number of interpretations 
present. In counting the total number in each category of ECG diag-
nosis, if both cardiologists had the same interpretation, only one 
diagnosis was counted. 
It should be remembered that the changes shown in Table I are 
net changes, and hence the actual changes which took place are not 
represented. In the category of MI, three observations are notable. 
The first observation is the small net increase in the total number 
of positive diagnoses after the label was provided. Individual changes 
by each cardiologist are greater. This suggests that the overall net 
changes in the total number of diagnoses does not truly reflect the 
actual changes that took place. The second observation is the net 
difference in the frequency counts for Doctor I and Doctor 2, which 
indicate that the changes were in opposite directions. The latter 
observation may suggest that the cardiologists' ECG interpretive 
behavior is discordant. However, if the number of infarcts identified 
by each cardiologist are compared, there is a difference of 
TABLE 4 
TOTAL NUMBER OF DIAGNOSES IN INFARCTION, ATRIAL ENLARGEMENT, VENTRICULAR 
ENLARGEMENT, AND REPOLARIZATION ABNORMALITIES BOTH BEFORE 
AND AFTER THE CLINICAL LABEL WAS AVAILABLE 
Total Number of Infarcts 
Number of Infarcts by Doctor 1 
Number of Infarcts by Doctor 2 
Total Number of Atrial Enlargements 
Number of Atrial Enlargements by Doctor 1 
Number of Atrial Enlargements by Doctor 2 
Total Number of Ventricular Enlargements 
Number of Venticular Enlargements by Doctor 1 
Number of Ventricular Enlargements by Doctor 2 
Total Number of Repolarizing Abnormalities 
Number of Repolarizing Abnormalities by Doctor 1 


































six (forty-three and forty-nine) before the label was provided, and 
the difference decreases to two (forty-eight and forty-six) after the 
introduction of the label. The reduction may suggest a decrease in 
the interobserver variation between the cardiologists. Similar results 
are observed in the interpretation of ventricular enlargement and 
repolarization changes except in the category of atrial enlargement. 
In the interpretation of atrial enlargement, the net increase in the 
total number of diagnoses is small, while the individual changes are 
relatively greater. Observation of the net differences contributed 
by both cardiologists suggests that their changes in the ECG inter-
pretations are in opposite directions. In addition, the difference 
in the frequency of atrial enlargement diagnoses contributed by both 
cardiologists is zero (twenty-one and twenty-one) before the label 
was provided, which increased to nineteen (thirty-two and thirteen) 
after the introduction of the label. The last two observations 
strongly suggest that their changes in the interpretations of atrial 
enlargement tend to be in opposite directions. However, this con-
clusion can only be made if the actual changes reflect the same 
changes. 
Based on the above observations, no conclusive statement can 
be made as to how the clinical label would affect the cardiologists' 
ECG interpretive behavior. The changes in the frequency of diagnosis 
in the four categories of ECG interpretations may be due to factors 
other than the effect of the clinical label. Also, the actual 
changes, which better display the cardiologists' behavior, are not 
shown. Hence, a more meticulous examination of the data is essential. 
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Last, the results show that there is a large number of in-
farctions present. The sample was chosen randomly in a consecutive 
fashion from the coronary care unit. This sample, therefore, does 
not represent the hospital population. Nevertheless, it is the 
changes in the interpretive behavior of the cardiologist that are of 
interest in this study. 
Availability of the Clinical Information 
in the Patient Data File 
The frequency count of the presence of the demographic and 
clinical information on the 100 labels is shown in Table 5. In the 
second column, the table also shows the frequency of informative 
clinical labeling. The latter statement needs further explanation. 
For instance, in the category of current cardiac medications, a 
second digitalis medication on thirty-three labels indicates that the 
label is informative in this respect in thirty-three cases out of the 
100 cases. Nevertheless, the absence of this information in sixty-
seven cases also means that these sixty-seven patients are not 
currently taking digitalis. Hence, the clinical label is informative 
in all 100 cases with respect to current cardiac medications. This 
also applies to the category of past medical history. With respect 
to other categories, the label is informative only in the cases where 
the information is present. 
The demographic information including height, weight, and 
age should be present on all of the labels. However, only 49 percent 
of the labels have the height and weight information. This was a 
data entry problem at the admitting office. In addition, during the 
TABLE 5 
FREQUENCY OF THE AVAILABILITY OF THE CLINICAL INFORMATION 
Information 




B. Clinical Information: 
1. Admitting Diagnosis 
2. Past Medical History: 
a. Myocardial Infarction 
b. Hypertension 
c. Coronary Artery Bypass Graft 
d. Valvular Surgery 
e. Rheumatic Fever 





4. Echocardiogram Diagnosis 
5. Cardiac Catherization Diagnosis 
6. Chest X-Ray 
Frequency of Clinical 
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7. Enzymes and Isoenzymes: 
a. Creatinine Kinase 
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period of data collection, there were no personnel in the Department 
of Cardiology to enter data on echocardiographic diagnosis. Hence, 
the echocardiographic diagnosis is absent on all the labels. 
The interpreted results of cardiac catherization are also 
absent from labels, because at the time the sample was collected only 
a few patients in the hospital had this information on file, and none 
of these patients was included in this study. 
The high frequency of positive past medical history reflects 
the type of patients in the sample. It suggests that close to 50 per-
cent of the patients in the sample had a history of hypertension or 
MI. It is not a coincidence to find that there are fifty-three to 
fifty-four infarction diagnoses (see Table 4). In addition, the high 
frequency of the presence of digitalis and diuretics medication indi-
cate that these patients has some form of cardiac problems. Hence, 
their ECGs most likely manifest some form of abnormality. 
Intraobserver Variations of the 
Two Cardiologists 
It is known that if a cardiologist interprets the same ECG 
twice, there is a significant possibility that the interpretations 
will differ. This section examines how often the cardiologists make 
conflicting diagnoses before and after the introduction of the clini-
cal label. The protocol described in Chapter II for the intraobserver 
variation study was followed. The analysis of the interpretations 
from the twenty-five ECGs is described below. 
In order to estimate the intraobserver variation before the 
clinical label was provided, the interpretations from the first 
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reading without the clinical label are compared to that of the second 
reading without the label. This comparison is conducted separately 
for each cardiologist. 
In order to estimate the intraobserver variation after the 
clinical label was provided, the interpretations from the first 
reading with the clinical label are compared to that of the second 
reading with the clinical label. Again, this comparison is conducted 
separately for each cardiologist. 
The results are displayed in Tables 6, 7, 8, and 9. Table 6 
shows the overall intraobserver variation of Doctor 1 in interpreting 
ECGs. There is an overall decrease in the disparity between diagnoses 
after the clinical label was provided. In interpreting ventricular 
enlargement, the decrease is as high as 50 percent. However, by the 
observation from Table 6 alone, it is inconclusive whether the 
reduction is significant or not. Hence, the three categories of ECG 
diagnoses are segmented into site specific diagnoses for further 
examination. 
Table 7 shows the frequency of disagreement in the diagnoses 
within a given category. Again, it shows a general trend of reduction 
after the clinical label was provided. In order to examine whether 
the reduction is statistically significant, the hypothesis that the 
frequency of disagreement was not affected by the presence of the 
clinical label was tested. A nonparametric one-tailed significance 
test was applied to test this hypothesis. The computed significance 
level (£ ~ 0.02) suggests that there was an effect. 
The statistical result suggests that there is a difference. 






OVERALL INTRAOBSERVER VARIATION OF DOCTOR 1 BEFORE AND 
AFTER THE INTRODUCTION OF THE CLINICAL LABEL 
Percent of Discordant 






NOTE: Sample size = twenty-five. 
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INTRAOBSERVER VARIATION OF DOCTOR 1 IN INTERPRETING ECGs 
Categories of ECG Diagnoses 
Myocardial Infarction: 
18.1, 18.2, 18.6 




Left Atrial Enlargement 
Left Ventricular Enlargement 
Right Ventricular Enlargement 
NOTE: Sample size twenty-five. 
Count of Discordant 
Diagnoses Before 
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OVERALL INTRAOBSERVER VARIATION OF DOCTOR 2 BEFORE AND 
AFTER THE INTRODUCTION OF THE CLINICAL LABEL 
Percent of Discordant 






NOTE: Sample size = twenty-five. 
Percent of Discordant 









INTRAOBSERVER VARIATION OF DOCTOR 2 IN INTERPRETING ECGs 
Categories of ECG Diagnoses 
Myocardial Infarction: 
18.1, 18.2, 18.6 




Left Atrial Enlargement 
Left Ventricular Enlargement 
Right Ventricular Enlargement 
NOTE: Sample size = twenty-five. 
Count of Discordant 
Diagnoses Before 
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However, the number of categories of ECG diagnoses and the sample size 
is small, so the conclusion drawn is weak. Clinically, the statisti-
cal result indicates that Doctor 1 became more consistent in the 
interpretation of the three categories of ECG diagnoses after the 
introduction of the clinical label. 
Table 8 shows the overall intraobserver variation of Doctor 2 
in interpreting the three categories of ECG diagnoses. The decrease 
in discordant diagnosis (22.7 percent to 6.7 percent) is large in 
the presence of clinical labeling. In interpreting ventricular 
enlargement, the reduction is as high as 100 percent. Based on this 
finding, the significance of this reduction is inconclusive. Hence, 
the three categories of ECG diagnoses are segmented into site specific 
diagnoses for further examination. 
Table 9 shows the frequency of discordant diagnoses under 
each category. To examine whether the decreases are statistically 
significant, the null hypothesis of no change in the interpretations 
was tested. A nonparametric one-tailed significance test was applied 
to test the null hypothesis. The computed significance level was 0.02 
which again suggests that the null hypothesis can be rejected. 
The statistical result suggests that the two sets of data are 
different. Again, because the number of categories of ECG diagnoses 
and the sample size were small, the conclusive statement is weak. 
Nevertheless, the statistical result indicates that Doctor 2 became 
more consistent in interpreting the four categories of ECG diagnoses 
after the label was made available. 
Above all, the intraobserver variation study shows that there 
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was an overall decrease in the intraobserver variation of each cardio-
logist in interpreting the three categories of ECG diagnoses. The 
decrease is statistically significant and comparatively greater in 
Doctor 2 than in Doctor 1. Clinically, it helps the cardiologist 
to make more consistent ECG interpretations and thus provide more 
consistent ECG interpretations to the attending physicians. 
Interobserver Variation between the 
Two Cardiologists 
It is known that very often cardiologists disagree among 
themselves in the interpretations of the same ECGs. Table 10 shows 
the overall results of the interobserver variation study. It should 
be noted that there is a large reduction in the frequency of dis-
agreement between the cardiologists in interpreting myocardial infarc-
tions after the introduction of the label. In Table 4, there are 
fifty-three and fifty-four total number of infarction diagnoses 
before and after the clinical label was provided, respectively. 
Out of these fifty-three diagnoses, they disagreed twenty-four times 
or 45 percent before the label was available to them; the frequency of 
disagreement decreased to thirteen times (24 percent) after the in-
troduction of the label. The decrease of forty-seven percent seems 
to strongly suggest that the reduction of the interobserver variation 
for MI is clinically important. For interpreting chamber enlargement, 
the changes in the frequency of disagreement are small. However, in 
order to test whether the changes are statistically significant, the 
three categories of ECG diagnoses are segmented into site-specific 





INTEROBSERVER VARIATION IN THE INTERPRETATION OF ECGs 
BETWEEN DOCTOR 1 AND DOCTOR 2 BEFORE AND AFTER 
THE CLINICAL LABEL WAS PROVIDED 








NOTE: Sample size = 100. 











Table 11 shows the interobserver variation for the specific 
categories of ECG diagnoses. In order to test whether the two sets 
of data are identical, the hypothesis of no change in behavior was 
tested. A nonparametric one-tailed significance test was applied to 
test the null hypothesis. The computer significance level was 0.11 
which is inconclusive since it is not significant. This lack of 
significance is probably attributable to lack of sample size. 
However, one important point which needs to be addressed is 
the fact that the frequency of disagreement in interpreting MI de-
creased from twenty-four to thirteen after the introduction of the 
label. The overall statistical results obtained from the two sets of 
data in Table 11 do not reflect this change because it is masked by 
the opposite effect in the category of atrial enlargement. On closer 
examination, one sees that the reduction of disagreement is especially 
great (see Table 11) in interpreting inferior infarctions (18.3, 18.4, 
and 18.9). Since the clinical information, which was available on the 
clinical label, is more helpful in interpreting infarction than 
chamber enlargements, it is logical to believe that the clinical label 
may be more helpful in reducing the frequency of disagreement between 
the cardiologists in interpreting infarctions. Indeed, the results are 
in agreement with the latter expectation. 
Finally, it must be noted that the changes in the interpreta-
tions may have been due to factors other than the effect of the 
clinical label, such as chance. 
ECG Diagnoses of 
Specific Sites 
Myocardial Infarction: 
18.1, 18.2, 18.6 




Left Atrial Enlargement 
TABLE 11 
INTEROBSERVER VARIATION IN THE INTERPRETATION OF ECGs 
BETWEEN DOCTOR 1 AND DOCTOR 2 UNDER THE SEGMENTED 
CATEGORIES OF ECG DIAGNOSES 
Frequency of Disagreement 








Left Ventricular Enlargement 6 
Right Ventricular Enlargement 3 
Total 49 
NOTE: Sample size = 100. 
Frequency of Disagreement 













Analysis of the Concurrent ECG Interpretive 
Behavior of Doctor 1 and Doctor 2 
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The concurrent behavior of the two cardiologists in interpret-
ing ECGs shows whether their interpretations converge or diverge. If 
the cardiologists read the same ECGs twice without the clinical label, 
the interpretations of the first reading and that of the second read-
ing should be the same. However, if there are any changes in their 
interpretations, it may be due to chance variation. The direction of 
concurrent changes in their interpretations determines the frequency 
of convergent or divergent diagnoses after the second reading. Since 
no other factor contributes to the changes except chance variance, 
these changes are presumably random, and it is logical to expect that 
the ratio of the frequency of convergent diagnoses to that of the 
divergent diagnoses will be ideally one. In addition, this ratio 
serves as a reference point for further comparative study of this 
ratio after the clinical label was introduced to the cardiologists. 
Furthermore, by this comparison, the effect of the clinical label 
on the cardiologists' ECG interpretive behavior may be uncovered. 
Table 12 shows the frequency of convergent and divergent 
diagnoses of the twenty-five ECGs (the twenty-five ECGS in the intra-
observer variation study) in the four categories of ECG diagnoses. 
The ratio of the total number of convergent diagnoses to that of the 
divergent diagnoses is twenty-eight to twenty-four and the result is 
1.17. As was expected, the ratio is very close to one. 
In order to observe the effect of the clinical label on the 
cardiologists' ECG interpretive behavior, the twenty-five ECGs, which 
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TABLE 12 
THE REFERENCE POINT OF THE CONVERGENT AND DIVERGENT BEHAVIOR OF 
DOCTOR 1 AND DOCTOR 2 IN THE INTERPRETATION OF ECGs 






















NOTE: Sample size twenty-five. The cardiologists were not provided with the clinical label in the 




were read four times by both cardiologists, are again examined. 
The first reading without the label is compared to that of the second 
time with the label provided, and changes in their interpretations 
are observed. These changes may be due to chance variation or the 
effect of the clinical label. The directions of changes in the inter-
pretations determine the number of convergent and divergent diagnoses. 
In Table 13, the overall results of the concurrent behavior of both 
cardiologists in the interpretations of the twenty-five ECGs are 
shown. The total frequency of convergent and divergent behavioral 
patterns is recorded under four categories of ECG diagnoses. It is 
observed that in the four categories of ECG diagnoses considered in 
the study, all show more convergent than divergent interpretations. 
The changes in interpreting repolarization changes (eighteen to 
eleven) are the greatest. 
Quantitatively, the ratio of the frequency of convergent 
diagnoses to that of the divergent diagnoses is thirty-eight to 
nineteen, indicating that there are two times more convergent diag-
noses than divergent diagnoses with the clinical label. 
Chance variance is probably the factor which contributes 
to the changes besides the effect of the clinical label. However, 
if this ratio is compared to the ratio of the reference point (1.17), 
the effects of chance variation may be eliminated. Hence, what re-
mains is the effect of the clinical label. The result of the ratio 
(2.00 to 1.17) was 1.71. It is reasonable to say that the clinical 
label caused approximately 1.71 times more convergent diagnoses than 
divergent diagnoses for the four categories of ECG diagnoses. This 
TABLE 13 
CONVERGENT AND DIVERGENT BEHAVIOR OF DOCTOR 1 AND 
DOCTOR 2 IN THE INTERPRETATION OF ECGs 






















NOTE: Sample size = twenty-five. Convergent means both cardiologists agree in the diagnosis of the 
same ECG after the clinical label is available to them. Divergent means both cardiologists disagree in 
the diagnosis of the same ECG after the clinical label is available to them. The cardiologists were pro-




finding shows that the clinical label has some effect on the cardio-
logists' ECG interpretive behavior and the effect seems to be in a 
positive direction. In simpler words, the clinical label seems to 
help both cardiologists to agree more in their interpretations. 
Clinically, this is important because it may make the interpretations 
less dependent on which cardiologist was reading the ECGs. 
It is appropriate at this time to examine each of the four 
categories of EGG diagnoses separately in order to observe the details 
of the behavior of both cardiologists before and after the clinical 
label was made available to them. Above all, the general trend in 
the details of the EGG interpretive behavior of both cardiologists 
is the same as that of the overall trend. The tables displaying the 
detailed examination of each category of the diagnoses in the twenty-
five EGGs are shown in Appendix D. 
Changes in the Specificity of ECG Diagnoses 
Before and After the Introduction of 
the Clinical Label 
The changes in the repolarization portion of an ECG may be 
attributable to numerous conditions. Thus, the interpretations of 
the repolarization changes vary in the degree of specificity. The 
data analysis in the study for repolarization changes emphasizes the 
changes in the specificity of the interpretations. In Table 14, the 
total frequency of changes in the specificity and the corresponding 
frequency of changes by the individual cardiologist is recorded. In 
the cases where there are concurrent changes of specificity, two 
changes are recorded. 
TABLE 14 
CHANGES IN THE SPECIFICITY OF THE INTERPRETATIONS 
OF REPOLARIZATION CHANGES 
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Type of Changes Frequency Count 
Nonspecific Diagnosis -> Specific Diagnosis: 
Total Number by Both Cardiologists 47 
Total Number by Doctor 1 20 
Total Number by Doctor 2 27 
Specific Diagnosis -> Nonspecific Diagnosis: 
Total Number by Both Cardiologists 1 
Total Number by Doctor 1 1 
Total Number by Doctor 2 a 
NOTE: Sample size = 100. 
-> = Direction of changes. 
Table 14 shows that there are a large number of changes in 
the specificity (23.5 percent) of the interpretations after the 
introduction of the label. In the one case where Doctor 1 changed 
interpretation from specific to nonspecific diagnosis, Doctor 2 
changed interpretation in the same direction. More information 
relating to the changes in the specificity of the EGG diagnoses may 
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be uncovered if the twenty-five EGGs selected for the intraobserver 
variation study are examined closely. The examination and its results 
are described below. 
Ideally, if the same EGGs are interpreted twice under the 
identical circumstances (without the clinical label), there should be 
no change in the specificity of the interpretations for the repolariza-
tion changes. Indeed, the results of the examination show that out of 
the twenty-five EGGs (the twenty-five EGGs from the intraobserver 
variation study), there is only one case (2 percent) where one of the 
cardiologists changed interpretation from a nonspecific diagnosis to 
a specific one. 
When the interpretations of the first reading without the 
clinical label are compared to that of the second reading with the 
clinical label, it is found that there are in total eighteen out 
of twenty-five EGGS (36 percent) where at least one of the cardiolo-
gists changed diagnoses from nonspecific ones to specific ones. Out 
of these eighteen times, there were seven times where both cardiolo-
gists changed their diagnoses concurrently. However, these changes 
again may be due to the effects of chance variance or the clinical 
label. If the effects of chance variance are eliminated, the major 
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effect of the clinical label may be uncovered. The reference point 
denotes the extent of the effect of chance variance. If subtracted 
from the total number of changes (eighteen) in the specificity of the 
interpretation after the introduction of the clinical label, the 
changes which are contributed by the effect of the label may be 
identified. The result of the subtraction is seventeen; this means 
that the label causes approximately seventeen times more specific 
ECG interpretations of the repolarization changes. 
Above all, the overwhelming number of cases where the 
specificity of the interpretations changes could not be explained by 
the effects of chance variation alone. The result indicates that 
there is some clinical information which may affect the interpretive 
behavior of the cardiologists. Therefore, it may be concluded that 
the clinical label does have a certain effect on the cardiologists' 
interpretation of the repolarization changes in ECGs. 
Type and Frequency of Clinical Information 
Present when Convergent or Divergent 
Behavior Was Observed 
It may be informative to observe the frequency with which 
certain clinical information appears on the clinical label when the 
convergent or divergent behavior of the cardiologists is present. If 
a specific piece of information appears frequently when their diag-
noses converge or diverge, it may suggest that the clinical informa-
tion may have some influence on the cardiologists' ECG interpretive 
behavior. The frequency of clinical information in the four cate-
gories of ECG interpretations is described below. 
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Myocardial Infarction (MI) 
Table 15 shows that the past medical history of MI appears 
quite frequently when there are convergent or divergent diagnoses of 
MI observed. For interpreting MI, it is known that a history of 
past infarction is an important piece of information. 
Also, the laboratory results of creatinine kinase and its MB 
isoenzymes are important information in the confirmation of infarc-
tions. The enzyme information appears more often (21 percent) in 
the cases where convergent diagnoses are present, as compared to 
12.5 percent in the cases where divergent diagnoses are observed. 
In addition, the information of past coronary artery bypass 
graft may be useful in diagnosing old infarcts. However, the informa-
tion is not specific enough because the site of the graft is not 
known. Hence, its usefulness may be limited. 
The high frequency of appearance of the clinical information 
on the clinical label when convergent diagnoses are present does not 
indicate any cause-effect relationship. For instance, the information 
of height and weight is present in high frequency, but it is hardly 
useful in verifying the presence of infarcts. On the other hand, it 
is known that the knowledge of past MI may help a cardiologist to 
identify an old infarction. In addition, creatinine kinase (CK) and 
CK-MB levels are important clinical information for detecting infarcts 
especially when the infarctions are patchy and the electrocardio-
graphic tracing does not show any abnormalities. The frequent 
appearance of these two types of clinical information, when conver-
gent diagnoses of infarction are observed, suggest that the clinical 
TABLE 15 
FREQUENCY THAT THE CLINICAL INFORMATION WAS PRESENT WHEN THE 
DIAGNOSES OF MYOCARDIAL INFARCTION WERE CONVERGENT OR 







Past Medical History: 
Past Myocardial Infarction 
Hypertension 
Coronary Artery Bypass Graft 
Valvular Surgery 
Rheumatic Fever 



























NOTE: Sample size = fifty-four. Count of convergent diagnoses = 
twenty-one; count of divergent diagnoses = eight. 
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information may have an influence in the interpretive process. Never-
theless, based on the findings in Table 15, there is not sufficient 
sample size to conclude that the three types of clinical information 
will help the two cardiologists to make better interpretations on the 
ECGs. 
Atrial Enlargement 
Table 16 shows the frequency of the clinical information 
appears when there are convergent or divergent diagnoses of atrial 
enlargement present. It is important to remember that the crucial 
information which may help in interpreting atrial enlargement are 
echocardiographic diagnoses and interpreted results of cardiac 
catherization. However, this information is absent in all the labels. 
The information of past infarction and hypertension may be 
useful information. Nevertheless, the data in the table suggest the 
contrary. In other words, the frequency of the presence of this 
information is higher when divergent diagnoses are present. 
The sample size is too small to conclude a relationship be-
tween the convergence or divergence in interpreting atrial enlargement 
and the appearance of the corresponding clinical information. 
Ventricular Enlargement 
Table 17 shows the frequency of the clinical information in 
the presence of convergent or divergent diagnoses of ventricular 
enlargement present. However, as in the case of atrial enlargement, 
the crucial information which may help the diagnostic process is 
absent on the clinical label. It seems that there is no association 
TABLE 16 
FREQUENCY THAT THE CLINICAL INFORMATION WAS PRESENT WHEN THE 
DIAGNOSES OF ATRIAL ENLARGEMENT WERE CONVERGENT OR 







Past Medical History: 
Past Myocardial Infarction 
Hypertension 
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NOTE: Sample size = thirty-two. Count of convergent diagnoses 
eight; count of divergent diagnoses = eleven. 
TABLE 17 
FREQUENCY THAT THE CLINICAL INFORMATION WAS PRESENT WHEN THE 
DIAGNOSES OF VENTRICULAR ENLARGEMENT WERE CONVERGENT OR 







Past Medical History: 
Past Myocardial Infarction 
Hypertension 
Coronary Artery Bypass Graft 
Valvular Surgery 
Rheumatic Fever 



























NOTE: Sample size = nineteen. Count of convergent diagnoses = 
eight; count of divergent diagnoses = six. 




The interpretations of repolarization changes in an ECG vary 
in specificity. In order to identify which clinical information is 
most likely to affect the changes, a frequency count of the appearance 
of the clinical information when there are changes in the specificity 
of the ECG diagnoses is compiled in a tabulated form. 
Out of the 100 ECGs, there are thirty-one instances where at 
least one of the cardiologists changed interpretations of the repolar-
ization changes from nonspecific diagnoses to specific ones. There 
are forty-seven changes by both cardiologists; of these forty-seven 
cases, there are forty-one cases (see Table 18) which have the clinical 
information of digitalis (85 percent) present. There are sixteen 
cases where both cardiologists had concurrent changes in the specific-
ity of their diagnoses from nonspecific diagnoses to specific ones. 
In these sixteen cases, all (100 percent) have the clinical informa-
tion of digitalis present on the clinical label. On close examination, 
it is found that in these forty-seven cases where the specificity of 
their diagnoses changed, the related changes in the computer codes 
are changed from 13.4 (Nonspecific ST-T Wave Abnormalities) to 13.2 
(Suspected Digitalis Effect) or 13.1 (Repolarizing Abnormalities 
Secondary to Digitalis Effect). It is known that digitalis mainly 
causes repolarization changes in an ECG. By the nature of these 
changes in the computer codes and the large number of cases where this 
TABLE 18 
FREQUENCY THAT THE CLINICAL INFORMATION WAS PRESENT WHEN THE 
DIAGNOSES OF REPOLARIZATION ABNORMALITIES WERE CHANGED 
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NOTE: Sample size = thirty-one. Count of changes from nonspecific to specific diagnoses 
seven; count of concurrent changes from nonspecific to specific diagnoses = sixteen. 







clinical information is present when there are changes in the specific-
ity of the diagnoses, it is logical to suspect that this clinical 
information definitely has an associated effect on the cardiologists' 
behavior in interpreting the repolarization changes in an ECG. 
On the contrary, there are totally 182 interpretations of the 
repolarization changes which do not involve any changes in the 
specificity of the diagnoses. Of these 182 interpretations, only 
thirty-five (20 percent) cases have the clinical information of 
digitalis type of medications. 
These findings strongly suggest that the changes in the 
specificity of ECG diagnoses are due to the appearance of the clinical 
information of digitalis. Thus, it may be concluded that the label 
has some clinical information which affects the cardiologists' inter-
pretation of the repolarization changes in ECGs. 
CHAPTER IV 
DISCUSSION AND SUMMARY 
Discussion 
In analyzing the intraobserver and interobserver variation of 
the cardiologists, the basic hypothesis is that the clinical informa-
tion improves the consistency of the cardiologists in interpreting 
ECGs. This hypothesis is supported by the general trend of the 
results shown in Chapter III. 
It should be noted that the sample size of 100 ECGs is too 
small for strong inferences. However, the results suggest that the 
clinical label has a positive effect on the interpretations of the 
ECGs by the cardiologists. It is logical to believe that if the 
sample size is increased, the general trend would most likely continue. 
The medical history shows that about 50 percent of the patients 
in the sample have a past history of MI. Actually, most of the pa-
tients in the sample are from the coronary care unit. By choosing 
more patients with cardiac problems, more interpretations of abnormal-
ities are found. Thus, more changes in their interpretive behavior may 
be observed in each category of diagnoses and the general trend 
deduced from these changes may be more substantial. 
In the cases where no changes in the interpretations are 
observed, it could be that the electrocardiographic findings were so 
convincing that no other information was necessary to verify the 
diagnoses. Thus, the label is of limited use in these instances. 
Availability of Clinical 
Information on the 
Clinical Label 
The more pertinent the information provided to the cardio-
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logists, the better the cardiologist would understand the patient and 
most likely, the more specific interpretations of the ECGs might be. 
In evaluating the availability of the clinical information, it is 
observed that the information is available in the patient data file. 
Most of the clinical information is likely to be more helpful to the 
cardiologists for MI interpretation than for diagnosing chamber 
enlargement. For instance, in interpreting infarction, the inter-
observer variation between the cardiologists decreased by 45.8 percent 
after the introduction of the clinical label. On the other hand, 
the frequency of disagreement in diagnosing atrial enlargement 
actually increased by 12.5 percent. The latter result may be due to 
the effect of chance variance or the clinical label. However, more 
consistency in the diagnoses of chamber enlargement may be observed 
if the pertinent information is present. In our study, information 
including echocardiographic diagnoses, interpreted results of cardiac 
catherization, and the chest X-ray diagnoses were either absent or 
present in low frequency (16 percent for chest X-ray diagnoses) on 
the label. This information is crucial for the interpretation of 
chamber enlargements. Clinically, the echocardiogram is more sensi-
tive than ECG for detecting chamber enlargement. Cardiac catheriza-
tion can provide hemodynamic information which is important in the 
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assessment of cardiac function. The latter two diagnostic techniques 
provide important cardiac function information, which is related to 
chamber enlargement, that the ECGs do not show. Hence, it is logical 
to expect more consistency in interpreting chamber enlargement if 
this information is present. 
Besides the demographic, electrolyte levels, and medical his-
tory information, current cardiac medications are recorded with 
moderate frequency. Most cardiac medications cause repolarization 
changes in ECGs, and hence, the effect of the presence of this in-
formation may be seen in the interpretations of the repolarization 
changes in the ECGs. 
Intraobserver Variation 
After the introduction of the clinical label, there was a 
reduction in the intraobserver variation for both cardiologists. For 
the interpretations of infarctions and chamber enlargements before 
the introduction of the clinical label, the overall average intra-
observer variation of Doctor 1 and Doctor 2 were 25 percent and 22.7 
percent, respectively. After the clinical label was made available 
to them, the corresponding average values were 14.7 percent and 6.7 
percent. A reduction of 10.3 percent and 16.0 percent for Doctor 1 
and Doctor 2, respectively, was observed. The computed significant 
level of 0.02 in the one-tailed significance test infers that the 
reductions are statistically significant. Chance variance alone 
could not account for the changes. Hence, it suggests that the 
clinical label had an effect on the interpretations of the 
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cardiologists and the effect seems to be in a positive direction. The 
label seems to have a greater effect on Doctor 2 than on Doctor 1 be-
cause the reduction is greater on Doctor 2 after the introduction 
of the label. Clinically, the cardiologists became more consistent 
in their interpretations of the ECGs after the label was provided. 
Interobserver Variation between 
the Cardiologists Before and 
After the Introduction of 
the Clinical Label 
The study accomplished by Davis (1957) showed that the ten 
experienced cardiologists only agreed unanimously on the ECG inter-
pretations in one-third of the 100 tracings. In half of the tracings, 
there was some disagreement while they had considerable dispute over 
twenty tracings. In other words, the interobserver variation among 
the cardiologists was more than 20 percent. In this study, it was 
found that the overall interobserver variation between the two car-
diologists was 12.3 percent before the clinical label was provided 
and decreased to 9.8 percent after the introduction of the label. 
The overall reduction was 2.5 percent. 
The small overall reduction masks the large decrease (45.8 
percent) in interpreting MI. This is expected because the clinical 
label has more information which may be helpful to the cardiologists 
in interpreting infarction. On the other hand, the interobserver 
variation is actually increased by 4 percent in interpreting chamber 
enlargement. Partially, it is probably attributable to the absence 
from the label of the echocardiographic diagnoses and the interpreted 
results of the cardiac catherization. In addition, the information of 
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chest X-ray diagnoses, which may be helpful in interpreting chamber 
enlargement, is not present on the label on most occasions (16 per-
cent). Clinically, this extent of reduction may be significant 
because if they disagree less, it makes the interpretations less 
dependent on which cardiologist is interpreting the ECGs for infarc-
tions. Conversely, this study also showed (computed significance 
level of 0.11) an overall statistically insignificant decrease in the 
frequency of disagreement after the label was provided. Based on this 
finding, it is suggestive but not conclusive that the clinical label 
helps to decrease the overall frequency of disagreement between the 
two cardiologists. 
Concurrent Changes by Doctor 1 
and Doctor 2 After the Label 
Is Provided 
In the evaluation of the concurrent changes by the two doctors, 
it is found that the frequency of converging diagnoses is approximately 
1.71 times that of the divergent diagnoses after the introduction of 
the clinical label. It is also found that this finding is mainly 
attributable to the effect of the label. In other words, in inter-
preting infarctions, chamber enlargements, and repolarizing abnormal i-
ties, the clinical label seems to help the two cardiologists to agree 
with each other more. This is logical because the cardiologists 
would probably have a better understanding of the patient's condition 
after the label was provided. Clinically, the label increases the 
consistency in the interpretations of ECGs by the cardiologists and 
makes the interpretations less dependent on which cardiologist is 
reading the ECGs. 
Change in the Specificity in 
Interpreting Repolarization 
Changes in an ECG 
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In the twenty-five ECGs selected for the intravariation study, 
there are sixteen cases where both cardiologists concurrently changed 
their diagnoses to be more specific. The changes that took place are 
changes from nonspecific interpretations of the repolarization changes 
to a specific diagnosis of definite digitalis effect. In all these 
sixteen cases, the clinical information of digitalis is present on the 
label. When the information is absent from the label, it informs the 
cardiologists that the patient is not currently taking digitalis-type 
medication. Hence, the effect of digitalis on the ECGs could be ruled 
out. Indeed, in the cases where this information was absent, the 
percent change in the specificity of ECG diagnoses was low. 
Above all, the results of this evaluation indicate that the 
clinical label has some clinical information which helps the cardio-
logists to make a more specific interpretation of the repolarization 
changes. Clinically, this is significant because there are numerous 
conditions which may contribute to the nonspecific changes in the 
repolarizing portion of an ECG. 
Type and Frequency of Clinical 
Information Present When There 
Is a Convergent or Divergent 
Behavior Observed 
Based on the frequency of the presence of a specific type of 
clinical information, no association can be made between the 
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information and the convergence of the diagnoses. However, in the 
cases where changes in the specificity of the diagnoses are involved, 
the nature of the changes in the computer codes indicates that 
digitalis is the information which contributes to the changes in the 
specificity. Thus, the clinical label helps the cardiologists to 
make a more specific interpretation of the repolarization changes in 
an ECG. 
Summary and Conclusion 
The results of the study show that the clinical information was 
available in the patient data file. After the clinical label is 
introduced to the cardiologists, there was a significant decrease 
(10.3 percent for Doctor 1 and 16.0 percent for Doctor 2) in their 
intraobserver variation for infarction and chamber enlargement inter-
pretations. The interobserver variation between them was reduced by 
45.8 percent for MI interpretations; the extent of decrease may be 
clinically significant. On the contrary, the overall interobserver 
variation for the interpretations of MI, atrial enlargements, and 
ventricular enlargements did not show a statistically significant de-
crease (16.3 percent to 13 percent), although there was a trend of 
reduction in the frequency of disagreement after the introduction of 
the label. After the clinical label was made available to them, there 
tended to be more concordant interpretations in diagnosing the four 
categories of cardiac diseases. The changes in the specificity of 
the ECG diagnoses were probably the effect of the clinical informa-
tion of digitalis. 
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In conclusion, although the sample size is small, the results 
of the study suggest that the clinical label contained some clinical 
information which had an effect on the cardiologists' interpretations 
of the ECGs. The results seem to suggest that with the help of the 
clinical label, the cardiologist may become more consistent in inter-
preting the four categories of abnormalities in the ECGs, will be more 
likely to agree in their diagnoses, and may make a more specific inter-
pretation in the repolarizing portion of an ECG. Clinically, these 
findings suggest that the clinical label helps to make the interpre-
tations less dependent on which cardiologist is reading the ECGs 
because of less intraobserver variation and less interobserver varia-
tion in diagnosing infarction. 
The conclusion of the findings is expected because the car-
diologists have a better understanding of the patient's health condi-
tion after gaining the knowledge of the patient's clinical informa-
tion. Instead of comparing the patient's ECG to the "normal ECG," 
the cardiologist considers each attribute on the label and makes 
adjustments in the interpretations. Hence, the interpretations 
become more specific to the patient. 
CHAPTER V 
FUTURE EFFORT 
The study is by no means complete. Further effort seems to 
be needed to improve this study and to make the results more conclu-
sive. The recommendations for further development of this study are 
described as follows: 
1. One of the cardiologists misunderstood the design of the 
study. Hence, the analysis for the modifiers was not finished. 
In order to complete this study, the analysis of the modifiers 
should be incorporated into the study. 
2. If the sample size is increased, the frequency count in 
each category of the diagnoses will most likely increase, and 
hence, the power of the statistical tests will also be increased. 
Furthermore, if the statistical tests are more powerful, the 
inferences that are drawn from these tests will be stronger. 
3. The echocardiographic diagnoses and the interpreted 
results of cardiac catherization should be made available in the 
patient data file. Comparing the electrocardiographic interpre-
tations, this information provides the "Gold Standard l1 in diag-
nosing some abnormalities including atrial enlargement and 
ventricular enlargement. 
4. Presently, the technician from the ECG laboratory obtains 
the necessary medical history for this study at bedside and enters 
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this information into the computer through a questionnaire after 
returning to the laboratory. This procedure is tedious and 
creates a sizeable workload, especially when the volume of ECG 
recording is high. However, it is possible to employ the existing 
equipment to transfer the information through the phone line to 
the patient data file when the ECG is recorded at bedside. This 
will reduce the present tedious procedure as well as the chance 
of error in transporting the information manually from the bedside 
to the computer terminal in the laboratory. Besides, it will im-
prove the efficiency of the system by speeding up the data entry 
process. 
5. One weakness in this study is the failure to identify 
which clinical information was being used when there was a 
change in the diagnosis. In future study, if there is some way 
that this information can be identified, the amount of information 
on the label can be reduced to a minimum because providing useful 
and concise clinical information is the prime purpose of this 
clinical label. 
6. Clinically, the real value of the label is the effect of 
the more specific interpretations on the management of the pa-
tient's health care. However, this effect was not studied and is 
unknown at present. A separate study may have to be done to 
assess the extent of this effect. 
APPENDIX A 
HELP SECTOR DECISIONS FROM CHEST X-RAY AND 
CARDIAC CATHERIZATION PROCEDURE 
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Description of HELP Sector Decisions 
Appendix A comprises three lists. The first and the second 
lists show all the possible HELP sector decisions from chest X-ray 
and cardiac catherization procedure, respectively. The last list is 
a list of abbreviations for the text in the HELP sector decisions from 
cardiac catherization procedure. 
Only four HELP sector decisions in chest X-ray were pertinent 
to the study. They are sectors 8, 9, 10, and 27. In the case of 
cardiac catherization, there were twenty-six HELP sector decisions 
which were of interest in this study: 1, 3, 5, 7, 9, 11, 12, 17, 18, 
20, 23, 25, 29, 30, 31, 34, 40, 43, 48, 50, 51, 52, 53, 55, and 57. 
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List One 
BLOCK #20.1 ********** CHEST ********** [ANY SECTOR] 
BLK MOD 1: INITIAL FINDING 
BLK MOD 2: NO CHANGE 
BLK MOD 3: INCREASED 
BLK MOD 4: DECREASED 
SOURCE FILE: $DATA.HELP.RESEARCH 
OWNER: RADIO. CHIP SECURITY: AAAAA 
ALWAYS SEND DESTINATION LIST: TO CALLING PROGRAM, TO INFA FOR DEBUGGING 
SEND (PRINT) ORDER: 66 
SECTOR 1 ===NORMAL POST OPERATIVE STATE= 
SECTOR 2 ===INFILTRATE/PNEUMONIA= 
SECTOR 3 ===PLEURAL EFFUSION= L/R 
SECTOR 4 ===HYPOAERATION/AIELECTASIS= L/R 
SECTOR 5 ===NO SIGNIFICANT ABNORMALITIES= 
SECTOR 6 ===RIB FRACTURE/S= 
SECTOR 7 ===PNEUMOTHORAX= 
SECTOR 8 ===CARDIO/PERICARDIAL ENLARGEMENT= 
SECTOR 9 ===OPD/EMPHYSEMA= 
SECTOR 10 ===CONGESTIVE HEART FAILURE= 
SECTOR 11 ===METASTASES= L/R 
SECTOR 12 ===LYMPHOMA= 
SECTOR 13 ===CHRONIC TUBERCULOSIS= 
SECTOR 14 ===COPD= 
SECTOR 15 ===NODULES= 
SECTOR 16 ===MASS= L/R 
SECTOR 17 ===CONTUSION= L/R 
SECTOR 18 ===INTERSTITIAL/ALVEOLAR EDEMA= 
SECTOR 20 ===ACTIVE TUBERCULOSIS= 
SECTOR 21 ===RESPIRATORY DISTRESS SYND= 
SECTOR 22 ===TACHYPNEA OF THE NEWBORN= 
SECTOR 23 ===HYALINE MEMBRANE DISEASE= 
SECTOR 24 ===PRE-SEC 2 INFILTRATE/PNEUMONIA= 
SECTOR 25 ===RIB LESION= 
SECTOR 26 ===HILAR MASS= 
SECTOR 27 ===PULMON ARTERY HYPERTENSION= 
SECTOR 28 ===ATRIAL ENLARGEMENT= 
SECTOR 29 ===OBSTRUCTION= L/R 
SECTOR 31 ===CALCIFIED CAROTID PLAQUES= 
SECTOR 32 ===PNEUMOPERITONEUM= 
SECTOR 33 ===NORMAL TUBE/CATHETER PLACEMENT= 
SECTOR 34 ===ANEURYSM= 
SECTOR 35 ===TUBE/LINE/CATHETER-SEE REPORT= 
SECTOR 40 ===HIATIAL HERNIA= 
SECTOR 41 ===BRONCHIECTASIS= L/R 
SECTOR 45 ===FLEURAL THICKENING= 
SECTOR 46 ===MEDIASTINUM WIDENING= 
SECTOR 50 ===FRACTURE/S= 
SECTOR 51 ===TUMOR= 
SECTOR 52 ===PACEMAKER PLACEMENT-SEE REPORT= 
SECTOR 53 ===NORMAL WIRE PLACEMENT= 
SECTOR 56 ===NORMAL PACEMAKER/WIRE PLACEMENT= 
SECTOR 58 ===NOUN FC1 
SECTOR 61 ===PNEUMOCONIOSIS= 
SECTOR 62 ===SEE DEPT. OF LABOR REPORT= 
SECTOR 63 ===SIGN. OTHER DIS-SEE BELOW= 
SECTOR 64 ===WIRE PLACEMENT-SEE REPORT= 
SECTOR 65 ===HEMATOMA= 




BLOCK #32.1 CATH LAB HELP DECISION SECTORS [ANY SECTOR] 
BLK MOD 1: MILD 
BLK MOD 2: MODERATE 
BLK MOD 3: MODERATELY SEVERE 
BLK MOD 4: SEVERE 
BLK MOD 5: SUSPECT 
BLK MOD 6: PROBABLE 
BLK MOD 7: DEFINITE 
SOURCE FILE: $DATA.HELP.RESEARCH 
OWNER: RADIO. CHIP SECURITY: AAAAA 
ALWAYS SEND DESTINATION LIST: TO INFA FOR DEBUGGING, TO PATIENT RECORD 
SECTOR 1 SIGNIFICANT LESIONS IN THE RIGHT CORONARY ARTERY 
SECTOR 2 INSIGNIFICANT LESIONS IN THE RIGHT CORONARY ARTERY 





























INSIGNIFICANT LESIONS IN THE LEFT ANTERIOR DESCENDING 
CORONARY ARTERY 
SIGNIFICANT LESIONS IN THE LEFT CIRCUMFLEX CORONARY ARTERY 
INSIGNIFICANT LESIONS IN THE LEFT CIRCUMFLEX CORONARY ARTERY 
SIGNIFICANT LESIONS IN THE LEFT MAIN CORONARY ARTERY 
INSIGNIFICANT LESIONS IN THE LEFT MAIN CORONARY ARTERY 
NO SIGNIFICANT CORONARY ARTERY LESIONS 
END DIASTOLIC VOLUME INDEX (ML/M**2) === *L 
EJECTION FRACTION OF LEFT VENTRICULAR ANGIOGRAM IS == 
END DIASTOLIC VOLUME OF LEFT VENTRICULAR ANGIOGRAM IS === ML 
END SYSTOLIC VOLUME OF LEFT VENTRICULAR ANGIOGRAM IS === ML 
EJECTION FRACTION OF LEFT VENTRICULAR ANGIOGRAM POST-NITRO 
IS == 
END DIASTOLIC VOLUME OF LEFT VENTRICULAR ANGIOGRAM POST-
NITRO IS === ML 
END SYSTOLIC VOLUME OF LEFT VENTRICULAR ANGIOGRAM POST-
NITRO IS === ML 
ELEVATED LEFT VENTRICULAR END-DIASTOLIC PRESSURE AT = 
ELEVATED RIGHT VENTRICULAR END-DIASTOLIC PRESSURE AT = 
ABNORMAL CONTRACTIONS IN THE = 
NO ABNORMAL CONTRACTIONS 
, 
PRESSURE GRADIENT ACROSS THE TRICUSPID VALVE (RESTING) === 
MMHG 
MITRAL VALVE AREA (MINIMUM VALUE) == == SQCM 
PROLAPSE OF THE MITRAL VALVE 
MITRAL REGURGITATION = 
= MITRAL STENOSIS = 
AORTIC VALVE AREA (MINIMUM VALUE) == == SQCM 
AORTIC REGURGITATION = 
SIGNIFICANT AORTIC REGURGITATION WITH ASSOCIATED STENOSIS 
NO AORTIC OR MITRAL VALVE REGURGITATION 
= AORTIC STENOSIS (GRADIENT) 
SECTOR 35 = AORTIC STENOSIS = 
SECTOR 36 NO MITRAL OR AORTIC REGURGITATION PRESENT (ANGIOGRAPHIC 
DATA) 
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SECTOR 37 NO MITRAL OR AORTIC STENOSIS WITH GRADE I or II REGURGITATION 
PRESENT 
SECTOR 38 = RV OUTFLOW STENOSIS 
SECTOR 39 = PULMONARY VALVULAR STENOSIS 
SECTOR 40 = HYPERTROPHIC SUBAORTIC STENOSIS (HEMODYNAMIC DATA) 
SECTOR 41 NO VALVULAR STENOSIS (HEMODYNAMIC DATA) 
SECTOR 42 NO MITRAL OR AORTIC VALVE STENOSIS 
SECTOR 43 CONSTRICTIVE PERICARDITIS OR RESTRICTIVE HEART DISEASE 
SECTOR 44 PATIENTS PULMONARY ARTERIOLAR RESISTANCE INDEX AT REST IS 
SECTOR 45 PATIENTS PULMONARY ARTERIOLAR RESISTANCE INDEX WITH EXERCISE 
IS == == 
SECTOR 46 PATIENTS SYSTEMIC VASCULAR RESISTANCE INDEX AT REST IS == == 
SECTOR 47 PATIENTS SYSTEMIC VASCULAR RESISTANCE INDEX WITH EXERCISE 
IS == == 
SECTOR 48 PATIENT HAS ELEVATED PULMONARY VASCULAR RESISTANCE = 
SECTOR 49 NO HIGHLY ABNORMAL VASCULAR RESISTANCE AT REST OR EXERCISE 
SECTOR 50 HYPERTENSIVE HEART DISEASE 
SECTOR 51 CONGESTIVE CARDIOMYOPATHY 
SECTOR 52 RESTRICTIVE CARDIOMYOPATHY 
SECTOR 53 NONSPECIFIED CARDIOMYOPATHY 
SECTOR 54 NO CARDIOMYOPATHIES 
SECTOR 55 NORMAL HEMODYNAMIC DATA 
SECTOR 56 NO SIGNIFICANT CORONARY ARTERY DISEASE 



























Abbreviations for HELP Sector Decisions from 










in the right coronary artery 
in the left anterior 
artery 
LCX DIS. in the left circumflex 
LMC DIS. in the left main coronary 
artery 
NO SIGNIF. COR. DIS. -- no significant coronary artery 
lesions 
E.F. -- ejection fraction of left ventricular angiogram --
LVEDV -- end diastolic volume of left ventricular angiogram 
is === ml 
ELEVATED LVEDP elevated left ventricular end diastolic 
pressure at = 
ELEVATED RVEDP elevated right ventricular end diastolic 
pressure at = 
ABNORMAL CONTRACTIONS IN THE -- (no abbreviations) 
NO ABNORMAL CONTRACTIONS -- (no abbreviations) 
MVA -- mitral value area (minimum value) == == sqcm 
MITRAL REGURG. -- mitral regurgitation = 
MITRAL STENOSIS -- = mitral stenosis = 
A.V.A. -- aortic value area (minimum value) -- -- sqcm 
A. REGUG -- aortic regurgitation = 
A.S. -- aortic stenosis (gradient) 
I.H.S.S. -- hypertrophic subaortic stenosis (hemodynamic 
data) 
CONST. PERICARD. OR RESTR. H. DIS. constrictive peri-
carditis or restric-
tive heart disease 
ELEVATED PVR -- patient has elevated pulmonary vascular 
resistance 
HTN H. DIS. -- hypertensive heart disease 
CONGo MYOPATHY -- congestive cardiomyopathy 
RESTR. MYOPATHY -- restrictive cardiomyopathy 
NONSPEC. MYOPATHY -- nonspecific cardiomyopathy 
NL HEMODYNAMICS -- normal hemodynamic data 
NL ANGIOGRAPHY -- normal angiographic data 
APPENDIX B 
COMPUTER CODES FOR ECG DIAGNOSES 
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Tables 19, 20, 21, and 22 list computer codes for EeG diag-
noses which are of interest in this study. These codes are separated 
into three categories, i.e., myocardial infarction, chamber enlarge-








































Left Ventricular Hypertrophy 
Right Ventricular Hypertrophy 
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Combined Right and Left Ventricular Hypertrophy 
Left Atrial Enlargement 
P-Wave Variant--Consider Left Atrial Abnormality 
Right Atrial Enlargement 
Combined Right and Left Atrial Enlargement 

























Repolariz.ation Abnormalities Secondary To 
Digitalis Effect 
Suspected Digitalis Effect 
Nonspecific ST-Segment Abnormalities 
Nonspecific ST-T Wave Abnormalities 
ST-Segment Abnormalities Consistent with 
Pericarditis/Myocarditis 
ST Abnormalities Consistent with Injury 
ST Abnormalities Consistent with Aneurysm 
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ST Abnormalities Consistent with Subendocardial 
Ischemia 
ST Segment Has Returned To Baseline 
ST Elevation 
ST Depression 
ST Abnormality--Plane Depression 
Prominent Upright U Waves 
Inverted U Waves 
Prolonged QT/QU Interval 






















Electrolyte Imbalance or Drug Effect 
Quinoidine Effect 
Primary T-Wave Abnormalities 
Nonspecific T-Wave Abnormalities 
T-Wave Abnormalities Associated with CNS Disease 
T-Wave Abnormalities Consistent with Pericarditis/ 
Myocarditis 
Peaked T Waves--Etio1ogy Undetermined 
T-Wave Inversion 
Primary T-Wave Abnorma1ities--Symmetric T Waves 
Abbreviation 
























Cannot Be Excluded 
Consistent With 
APPENDIX C 
DEFINITION OF CHANGES IN THE ECG DIAGNOSES 
Myocardial Infarction 





18.1 = 18.2 = 18.6 
18.3 = 18.4 = 18.9 
18.7 18.8 
18.5 is unique. 
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Definition of a change: The change in computer codes between 
groups is a change. 
Chamber Enlargement 
Equivalent groups are: 
1. 17.3 17.1 and 17.2 
2. 17.7 = 17.4 and 17.6 
3. 17.5 and 17.8 are unique. 
Definition of a change: The change in computer codes between 
groups is a change. 
Repo1arizing Abnormalities 





13.8 = 13.11 
All other codes are unique. 
Definition of a change: The change in computer codes between 
groups is a change. 
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TABLE 23 
CHANGES IN THE SPECIFICITY OF ECG DIAGNOSES 





13.6 or 13.10 13.7 
13.3, 13.4 13.1, 13.2, 13.5, 13.7, 13.8 
QT Waves: 
15.1, 15.2 15.3, 15.3, 15.5, 15.6, 15.7, 15.8 
T Waves: 
16.2, 16.6 16.1, 16.3, 16.4, 16.5 
NOTE: The definition of change in specificity is the change in 
computer codes between the two columns is a change in the specificity 
of the diagnosis. 
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Group I modifiers are: 
1. Equivalent modifiers are AC, HY, and EL. 
2. Other unique modifiers are OL, and AU. 
3. If a different modifier is used, it is a change except the 
ones defined as equivalent. 
Group II modifiers are shown in Table 24. 
TABLE 24 
DEFINITION OF CHANGES IN MODIFIERS 
Scale Modifiers 
0-25 Percent CO = CW = CE 
25-50 Percent PO 
50-75 Percent PR 
> 75 Percent Definite 
NOTE: Definition of a change is a difference of > 50 percent 
between two modifiers is a change. 
APPENDIX D 
CONCURRENT CHANGES OF BOTH CARDIOLOGISTS IN SEGMENTED 
CATEGORY OF ECG INTERPRETATION 
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Description of HELP Sector Decisions 
Appendix D is comprised of three lists. The first and the 
second lists show all the possible HELP sector decisions from chest x-
ray and cardiac catherization procedure, respectively. The last list 
is a list of abbreviations for the text in the HELP sector decisions 
from cardiac catherization procedure. 
Only four HELP sector decisions in chest X-ray were pertinent 
to the study. They are sector numbers 8, 9, 10, and 27. In the case 
of cardiac catherization, there were twenty-six HELP sector decisions 
which were of interest in this study. They are listed as follows: 
1, 3, 5, 7, 9, 11, 12, 17, 18, 20, 23, 25, 29, 30, 31, 34, 40, 43, 48, 
50, 51, 52, 53, 55, and 57. 
Doctor 1 
No -> Yes 
No -> Yes 
No -> Yes 
No -> Yes 
Yes -> No 
Yes -> No 
Yes -> No 
Yes -> No 
No -> No 
No -> No 
No -> No 
No -> No 
Yes -> Yes 
Yes -> Yes 
Yes -> Yes 
Yes -> Yes 
TABLE 25 
CONCURRENT BEHAVIOR OF DOCTOR 1 AND DOCTOR 2 IN THE 
DIAGNOSIS OF ANTEROSEPTAL, ANTERIOR, OR 
ANTEROLATERAL INFARCTION 
Doctor 2 Frequency 
Yes -> Yes 0 
No -> No 0 
No -> Yes 1 
Yes -> No 0 
Yes -> Yes 0 
No -> No 0 
No -> Yes 0 
Yes -> No 0 
Yes -> Yes 0 
No -> No 18 
No -> Yes 0 
Yes -> No 0 
Yes -> Yes 6 
No -> No 0 
No -> Yes 0 
Yes -> No 0 
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Count 
NOTE: Sample size = twenty-five. No = ECG diagnosis does not 
have any of these computer codes; other codes for infarction at dif-
ferent locations may be present. Yes = ECG diagnosis has one of these 
computer codes; other codes for infarction at different locations may 
also be present. -> = the direction of changes in diagnoses from 
reading without clinical label to reading with the label. 
NOTE: Computer codes are: lB.l, Anterospetal Infarction; lB.2, 
Anterior Infarction; and lB.6, Anterolateral Infarction. 
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TABLE 26 
FREQUENCY OF CONVERGENT AND DIVERGENT DIAGNOSES 
Direction of Changes 
Doctor 1 Doctor 2 Frequency Count 
Divergent 
Diagnoses No -> Yes No -> No 0 
Convergent 
Diagnoses No -> Yes No -> Yes 1 
NOTE: Sample size = twenty-five. No and Yes have the same mean-
ing as shown in Table 25. 
NOTE: There was a total of seven patients who had one of these 
codes (18.1, 18.2, 18.6) in their diagnoses. 
TABLE 27 
CONCURRENT BEHAVIOR OF DOCTOR 1 AND DOCTOR 2 IN DIAGNOSING 
INFERIOR, POSTERIOR, OR INFEROPOSTERIOR INFARCTION 
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Doctor 1 Doctor 2 Frequency Count 
No -> Yes 
No -> Yes 
No -> Yes 
No -> Yes 
Yes -> No 
Yes -> No 
Yes -> No 
Yes -> No 
No -> No 
No -> No 
No -> No 
No -> No 
Yes -> Yes 
Yes -> Yes 
Yes -> Yes 
Yes -> Yes 
Yes -> Yes 
No -> No 
No -> Yes 
Yes -> No 
Yes -> Yes 
No -> No 
No -> Yes 
Yes -> No 
Yes -> Yes 
No -> No 
No -> Yes 
Yes -> No 
Yes -> Yes 
No -> No 
No -> Yes 

















NOTE: Sample size = twenty-five. No means the ECG diagnosis does 
not have any of these codes; other codes for infarction at different 
sites may be present. Yes means the ECG diagnosis has one of these 
computer codes; other codes for infarction at different sites may 
also be present. 
NOTE: Computer codes: 18.3, Inferior Infarction; 18.4, Posterior 
Infarction; and 18.9, Inferoposterior Infarction. 
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TABLE 28 
FREQUENCY OF CONVERGENT AND DIVERGENT CHANGES 
Direction of Changes 
Doctor 1 Doctor 2 Frequency Count 
Divergent 
Diagnoses No -> Yes No -> No 1 
Convergent 
Diagnoses Yes -> No No -> No 4 
No -> No Yes -> No 
No -> Yes No -> Yes 
NOTE: Sample size = twenty-five. 
NOTE: There was a total of nine patients who had one of these 
computer codes (18.3, 18.4, 18.9) in their diagnoses. 
Doctor 1 
No -> Yes 
No -> Yes 
No -> Yes 
No -> Yes 
Yes -> No 
Yes -> No 
Yes -> No 
Yes -> No 
No -> No 
No -> No 
No -> No 
No -> No 
Yes -> Yes 
Yes -> Yes 
Yes -> Yes 
Yes -> Yes 
NOTE: 
TABLE 29 
CONCURRENT BEHAVIOR OF DOCTOR 1 AND DOCTOR 2 IN 
THE DIAGNOSIS OF LATERAL INFARCTION 
Doctor 2 Frequency 
Yes -> Yes 0 
No -> No 1 
No -> Yes 0 
Yes -> No 1 
Yes -> Yes 0 
No -> No 0 
No -> Yes 0 
Yes -> No 0 
Yes -> Yes 1 
No -> No 20 
No -> Yes 0 
Yes -> No 1 
Yes -> Yes 0 
No -> No 0 
No -> Yes 1 
Yes -> No 0 
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Count 
Sample size = twenty-five. No means the ECG diagnosis does 
not have this code (18.5); other codes for infarction at different 
sites may be present. Yes means the ECG diagnosis has this computer 
code (18.5); other codes for infarction at different sites may also be 
present. 
NOTE: Computer code: 18.5, Lateral Infarction. 
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TABLE 30 
FREQUENCY OF CONVERGENT AND DIVERGENT CHANGES 
Direction of Changes 
Doctor 1 Doctor 2 Frequency Count 
Divergent No -> Yes No -> No 2 
Diagnoses No -> Yes Yes -> No 
Convergent Yes -> Yes No -> Yes 2 
Diagnoses No -> No Yes -> No 
NOTE: Sample size = twenty-five. 
NOTE: There was a total of five patients who had a diagnosis of 
lateral infarction (18.5). 
TABLE 31 
CONCURRENT BEHAVIOR OF DOCTOR 1 AND DOCTOR 2 IN THE 
DIAGNOSIS OF INFEROLATERAL INFARCTION 
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Doctor 1 Doctor 2 Frequency Count 
No -> Yes Yes -> Yes 0 
No -> Yes No -> No 1 
No -> Yes No -> Yes 0 
No -> Yes Yes -> No 0 
Yes -> No Yes -> Yes 1 
Yes -> No No -> No 1 
Yes -> No No -> Yes 0 
Yes -> No Yes -> No 0 
No -> No Yes -> Yes 0 
No -> No No -> No 22 
No -> No No -> Yes 0 
No -> No Yes -> No 0 
Yes -> Yes Yes -> Yes 0 
Yes -> Yes No -> No 0 
Yes -> Yes No -> Yes 0 
Yes -> Yes Yes -> No 0 
NOTE: Sample size = twenty-five. No means the ECG diagnosis does 
not have this computer code (18.7) ; other codes for infarction at 
different sites may be present. Yes means the ECG diagnosis has this 
computer code; other codes for infarction at different locations may 
be present. 
NOTE: Computer code: 18.7, Infero1atera1 Infarction. 
TABLE 32 
FREQUENCY OF CONVERGENT AND DIVERGENT CHANGES 
Direction of Changes 
Doctor 1 Doctor 2 Frequency 
Divergent No -> Yes No -> No 2 
Diagnoses Yes -> No Yes -> Yes 
Convergent Yes -> No No -> No 1 
Diagnoses 
NOTE: Sample size = twenty-five. 
NOTE: There was a total of three patients who had this code 




CONCURRENT BEHAVIOR OF DOCTOR 1 AND DOCTOR 2 IN THE 
DIAGNOSIS OF APICAL INFARCTION 
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Doctor 1 Doctor 2 Frequency Count 
No -> Yes 
No -> Yes 
No -> Yes 
No -> Yes 
Yes -> No 
Yes -> No 
Yes -> No 
Yes -> No 
No -> No 
No -> No 
No -> No 
No -> No 
Yes -> Yes 
Yes -> Yes 
Yes -> Yes 
Yes -> Yes 
Yes -> Yes 
No -> No 
No -> Yes 
Yes -> No 
Yes -> Yes 
No -> No 
No -> Yes 
Yes -> No 
Yes -> Yes 
No -> No 
No -> Yes 
Yes -> No 
Yes -> Yes 
No -> No 
No -> Yes 

















NOTE: Sample size = twenty-five. No means the ECG diagnosis does 
not have this computer code (18.10); other codes for infarction at 
different sites may be present. Yes means the ECG diagnosis has this 
computer code; other codes for infarction at different locations may 
be present. 
NOTE: Computer code: 18.10, Apical Infarction. 
Doctor 1 
No -> Yes 
No -> Yes 
No -> Yes 
No -> Yes 
Yes -> No 
Yes -> No 
Yes -> No 
Yes -> No 
No -> No 
No -> No 
No -> No 
No -> No 
Yes -> Yes 
Yes -> Yes 
Yes -> Yes 
Yes -> Yes 
NOTE: 
TABLE 34 
CONCURRENT BEHAVIOR OF DOCTOR 1 AND DOCTOR 2 IN THE 
DIAGNOSIS OF ATRIAL ENLARGEMENT 
Doctor 2 Frequency 
Yes -> Yes 2 
No -> No 1 
No -> Yes 0 
Yes -> No 1 
Yes -> Yes 0 
No -> No 1 
No -> Yes 0 
Yes -> No 0 
Yes -> Yes 0 
No -> No 13 
No -> Yes 0 
Yes -> No 1 
Yes -> Yes 4 
No -> No 1 
No -> Yes 1 
Yes -> No 0 
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Sample size = twenty-five. No means the ECG diagnosis does 
not have this computer code (17.4). Yes means the ECG diagnosis has 
this computer code. 
NOTE: Computer code: 17.4, Left Atrial Enlargement. 
TABLE 35 
FREQUENCY OF CONVERGENT AND DIVERGENT DIAGNOSES 
Direction of Changes 
Doctor 1 Doctor 2 Frequency 
Divergent No -> Yes No -> No 2 
Diagnoses No -> Yes Yes -> No 
Convergent No -> Yes Yes -> Yes 5 
Diagnoses Yes -> Yes No -> Yes 
No -> No Yes -> No 
NOTE: Sample size = twenty-five. 
NOTE: There was a total of twelve patients who had this code 




CONCURRENT BEHAVIOR OF DOCTOR 1 AND DOCTOR 2 IN THE 
DIAGNOSIS OF VENTRICULAR ENLARGEMENT 
Doctor 1 Doctor 2 Frequency 
No -> Yes Yes -> Yes 0 
No -> Yes No -> No 1 
No -> Yes No -> Yes 2 
No -> Yes Yes -> No 0 
Yes -> No Yes -> Yes 0 
Yes -> No No -> No 1 
Yes -> No No -> Yes 0 
Yes -> No Yes -> No 0 
No -> No Yes -> Yes 0 
No -> No No -> No 16 
No -> No No -> Yes 0 
No -> No Yes -> No 1 
Yes -> Yes Yes -> Yes 2 
Yes -> Yes No -> No 0 
Yes -> Yes No -> Yes 3 
Yes -> Yes Yes -> No 0 
NOTE: Sample size = twenty-five. No means the ECG diagnosis 
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did not have one of these computer codes (17.1 or 17.2). Yes means 
the ECG diagnosis had one of these computer codes. 
NOTE: 17.1, Left Ventricular Enlargement; 17.2, Right Ventricular 
Enlargement. 
TABLE 37 
CONCURRENT DIRECTION OF CHANGES IN THE DIAGNOSIS OF 
VENTRICULAR ENLARGEMENT BY DOCTOR 1 
AND DOCTOR 2 
Direction of Changes 
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Doctor 1 Doctor 2 Frequency Count 
Divergent No -> Yes No -> No 1 
Diagnoses 
Convergent Yes -> No No -> No 7 
Diagnoses Yes -> Yes No -> Yes 
No -> Yes No -> Yes 
No -> No Yes -> No 
NOTE: Sample size = twenty-five. 
NOTE: There was a total of eight patients who had at least one 
of these codes (17.1 or 17.2) in their ECG diagnoses. 
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TABLE 38 
CONCURRENT BEHAVIOR OF DOCTOR 1 AND DOCTOR 2 IN THE DIAGNOSIS OF 
THE PRESENCE OR ABSENCE OF REPOLARIZING ABNORMALITIES 
Doctor 1 Doctor 2 Frequency Count 
No -> No No -> No 2 
No -> No No -> Yes 3 
No -> No Yes -> No 2 
No -> No Yes -> Yes 3 
Yes -> Yes No -> No 1 
Yes -> Yes No -> Yes 0 
Yes -> Yes Yes -> No 1 
Yes -> Yes Yes -> Yes 2 
Yes -> No No -> No 6 
Yes -> No No -> Yes 0 
Yes -> No Yes -> No 1 
Yes -> No Yes -> Yes 0 
No -> Yes No -> No 3 
No -> Yes No -> Yes 1 
No -> Yes Yes -> No 1 
No -> Yes Yes -> Yes 1 
NOTE: Sample size = twenty-five. No means there are no repo1ariz-
ing abnormalities in the diagnosis. Yes means there are repo1arizing 
abnormalities in the diagnosis. 
TABLE 39 
CONCURRENT BEHAVIOR OF DOCTOR 1 AND DOCTOR 2 IN THE CHANGES 
OF SPECIFICITY IN DIAGNOSING REPOLARIZING ABNORMALITIES 
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Doctor 1 Doctor 2 Frequency Count 
NS -> S NS -> S 6 
NS -> S NS <- S 0 
NS -> S No -> No 2 
NS -> S Yes -> Yes 0 
NS -> S No -> Yes 0 
NS -> S Yes -> No 0 
No -> No NS -> S 1 
Yes -> Yes NS -> S 0 
No -> Yes NS -> S 1 
Yes -> No NS -> S 0 
NS <- S NS -> S 0 
NS <- S NS <- S 0 
NS <- S Yes -> No 0 
NOTE: Sample size = twenty-five. NS = nonspecific; S = specific; 




No means there are no repo1arizing abnormalities in the 
Yes means there are repo1arizing abnormalities in the 
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